Login Register Cart 0
Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Clinical Overview of Arthritis with a Focus on Management Options and Preventive Lifestyle Measures for its Control

Author(s): Umesh Chandra Gupta*, Subhas Chandra Gupta and Saira Sugandh Gupta

Volume 18, Issue 5, 2022

Published on: 06 April, 2022

Page: [476 - 486] Pages: 11

DOI: 10.2174/1573401318666220204095629

Price: $65

Abstract

Arthritis is the spectrum of conditions that cause swelling and tenderness of one or more body joints with key symptoms of joint pain and stiffness. Its progression is closely linked to age. Although there are a number of arthritis types, such as ankylosing, gout, joint infections, juvenile idiopathic, reactive, and septic, the two most common types are osteoarthritis and rheumatoid arthritis. Osteoarthritis causes the articulating smooth cartilage that covers the ends of bones, forming a joint, to break down. Rheumatoid arthritis is a disease in which the immune system attacks joints, beginning with the cartilaginous lining of the joints. The latter is considered a systemic disease, i.e., affecting many parts of the body, but the respiratory system is involved in 10 to 20% of all mortality. Osteoarthritis is one of the leading causes of disability globally. Several preventive measures to control arthritis have been suggested, such as using analgesics, non-steroid anti-inflammatory drugs, moderate to vigorous physical activity and exercise, reducing sedentary hours, getting adequate sleep, and maintaining healthy body weight. Foods including a Mediterranean diet rich in fruits and vegetables, fish oil, medicinal plants, and microbiota are vital protective methods. The intake of vitamins, such as A and C, minerals, e.g., selenium and zinc, polyunsaturated and n-3 fatty acids, is also a significant preventive measure.

Keywords: Curcumin, chondroitin, environment, genetics, glucosamine, microbiota, obesity, rheumatoid.

« Previous Next »
Graphical Abstract

[1]
Oliviero F, Paolo S, Paolo S, Leonardo P. The Mediterranean Diet and Arthritis.In: Preedy V, Watson R, Eds.The Mediterranean Diet. San Diego: Academic Press 2014; pp. 461-72.
[2]
Sacks JJ, Harrold LR, Helmick CG, Gurwitz JH, Emani S, Yood RA. Validation of a surveillance case definition for arthritis. J Rheumatol 2005; 32(2): 340-7.
[PMID: 15693097]
[3]
Arthritis Symptoms and Causes 2018. Available from: https://www.mayoclinic.org/diseasesconditions/arthritis/symptoms-causes/syc-20350772
[4]
Zhou Y, Wang T, Hamilton JL, Chen D. Wnt/βcatenin signaling in osteoarthritis and in other forms of arthritis. Curr Rheumatol Rep 2017; 19(9): 53.
[http://dx.doi.org/10.1007/s11926-017-0679-z] [PMID: 28752488]
[5]
Tang CH. Research of pathogenesis and novel therapeutics in arthritis. Int J Mol Sci 2019; 20(7): 1646.
[http://dx.doi.org/10.3390/ijms20071646] [PMID: 30987068]
[6]
Hunt ER, Papathomas A. Being physically active through chronic illness: Life experiences of people with arthritis. Qual Res Sport Exerc Health 2020; 12(2): 242-55.
[http://dx.doi.org/10.1080/2159676X.2019.1601637]
[7]
Carvalho AMS, Heimfarth L, Santos KA, et al. Terpenes as possible drugs for the mitigation of arthritic symptoms - A systematic review. Phytomedicine 2019; 57: 137-47.
[http://dx.doi.org/10.1016/j.phymed.2018.10.028] [PMID: 30668316]
[8]
Lai JH, Ling XC, Ho LJ. Useful message in choosing optimal biological agents for patients with autoimmune arthritis. Biochem Pharmacol 2019; 165: 99-111.
[http://dx.doi.org/10.1016/j.bcp.2019.03.007] [PMID: 30876919]
[9]
Mandal A. Arthritis history. News Medical Life Sciences. 2019. Available from: https://www.news-medical.net/health/Arthritis-History.aspx
[10]
Babaie F, Hasankhani M, Mohammadi H, et al. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates. Immunol Lett 2018; 196: 52-62.
[http://dx.doi.org/10.1016/j.imlet.2018.01.014] [PMID: 29409751]
[11]
Horneff G, Burgos-Vargas R. Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol 2009; 27(4)(Suppl. 55): S131-8.
[PMID: 19822060]
[12]
Soleimanifar N, Nicknam MH, Bidad K, et al. Effect of food intake and ambient air pollution exposure on ankylosing spondylitis disease activity. Adv Rheumatol 2019; 59(1): 9.
[http://dx.doi.org/10.1186/s42358-019-0051-2] [PMID: 30777138]
[13]
Raychaudhuri SP, Raychaudhuri SK. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Res Ther 2017; 19(1): 51.
[http://dx.doi.org/10.1186/s13075-017-1249-5] [PMID: 28270233]
[14]
Dashti N, Mahmoudi M, Aslani S, Jamshidi A. HLA-B*27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene 2018; 670: 15-21.
[http://dx.doi.org/10.1016/j.gene.2018.05.092] [PMID: 29803000]
[15]
Sheth T, Pitchumoni CS, Das KM, Das KM. Musculoskeletal manifestations in inflammatory bowel disease: A revisit in search of immunopathophysiological mechanisms. J Clin Gastroenterol 2014; 48(4): 308-17.
[http://dx.doi.org/10.1097/MCG.0000000000000067] [PMID: 24492406]
[16]
Reis J, Vender R, Torres T. Bimekizumab: The first dual inhibitor of interleukin (IL)-17A and IL-17F for the treatment of psoriatic disease and ankylosing spondylitis. BioDrugs 2019; 33(4): 391-9.
[http://dx.doi.org/10.1007/s40259-019-00361-6] [PMID: 31172372]
[17]
Hu S, Zuo X, Li Y. Coexistence of systemic sclerosis and ankylosing spondylitis: A case report and literature review. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2018; 43(11): 1263-5.
[http://dx.doi.org/10.3390/nu10070908] [PMID: 30012973]
[18]
Ma S, Wang DD, Ma CY, Zhang YD. microRNA-96 promotes osteoblast differentiation and bone formation in ankylosing spondylitis mice through activating the Wnt signaling pathway by binding to SOST. J Cell Biochem 2019; 120(9): 15429-42.
[http://dx.doi.org/10.1002/jcb.28810] [PMID: 31111563]
[19]
van Steenbergen HW, da Silva JAP, Huizinga TWJ, van der Helm-van Mil AHM. Preventing progression from arthralgia to arthritis: Targeting the right patients. Nat Rev Rheumatol 2018; 14(1): 32-41.
[http://dx.doi.org/10.1038/nrrheum.2017.185] [PMID: 29118439]
[20]
Yücel AE, Kart-Köseoglu H, Enünlü CT, Ozdemir FN. Common articular problems in chronic hemodialysis patients and relationships with various parameters. Dial Transplant 2005; 34(4): 224-37.
[21]
Burgers LE, Ten Brinck RM, van der Helm-van Mil AHM, van der Helm-van Mil AHM. Is joint pain in patients with arthralgia suspicious for progression to rheumatoid arthritis explained by subclinical inflammation? A cross-sectional MRI study. Rheumatology (Oxford) 2019; 58(1): 86-93.
[http://dx.doi.org/10.1093/rheumatology/key220] [PMID: 30137540]
[22]
Watt FE. Musculoskeletal pain and menopause. Post Reprod Health 2018; 24(1): 34-43.
[http://dx.doi.org/10.1177/2053369118757537] [PMID: 29412042]
[23]
Crout TM, Lennep DS, Kishore S, Majithia V. Systemic vasculitis associated with immune check point inhibition: Analysis and review. Curr Rheumatol Rep 2019; 21(6): 28.
[http://dx.doi.org/10.1007/s11926-019-0828-7] [PMID: 31115712]
[24]
Johnson J. Arthritis vs. Arthralgia: What’s the difference? Medical News Today 2020. 2020.
[25]
Madell R. Arthrtis vs. Arthralgia: What is the difference? Healthline (Bhavnagar) 2019. Available from: https://www.healthline.com/health/rheumatoid-arthritis/arthralgia
[26]
Mayo Foundation for medical education and research. Available from: https://www.mayoclinic.org/diseases-conditions/gout/symptoms-causes/syc-20372897
[27]
Zhang T, Yang F, Li J, Pan Z. Gout of the axial joint-A patient level systemic review. Semin Arthritis Rheum 2019; 48(4): 649-57.
[http://dx.doi.org/10.1016/j.semarthrit.2018.04.006] [PMID: 29804629]
[28]
Gupta MK, Singh JA. Cardiovascular disease in gout and the protective effect of treatments including urate-lowering therapy. Drugs 2019; 79(5): 531-41.
[http://dx.doi.org/10.1007/s40265-019-01081-5] [PMID: 30868398]
[29]
Fields TR. The challenges of approaching and managing gout. Rheum Dis Clin North Am 2019; 45(1): 145-57.
[http://dx.doi.org/10.1016/j.rdc.2018.09.009] [PMID: 30447743]
[30]
Mehmood A, Zhao L, Wang C, et al. Management of hyperuricemia through dietary polyphenols as a natural medicament: A comprehensive review. Crit Rev Food Sci Nutr 2019; 59(9): 1433-55.
[http://dx.doi.org/10.1080/10408398.2017.1412939] [PMID: 29278921]
[31]
Bailey CJ. Uric acid and the cardio-renal effects of SGLT2 inhibitors. Diabetes Obes Metab 2019; 21(6): 1291-8.
[http://dx.doi.org/10.1111/dom.13670] [PMID: 30762288]
[32]
Luna G, Dolzhenko AV, Mancera RL. Inhibitors of xanthine oxidase: Scaffold diversity and structure-based drug design. ChemMedChem 2019; 14(7): 714-43.
[http://dx.doi.org/10.1002/cmdc.201900034] [PMID: 30740924]
[33]
Perez-Ruiz F, Dalbeth N. Combination urate-lowering therapy in the treatment of gout: What is the evidence? Semin Arthritis Rheum 2019; 48(4): 658-68.
[http://dx.doi.org/10.1016/j.semarthrit.2018.06.004] [PMID: 30075988]
[34]
Luo L, Xiang Q, Deng Y, et al. Gout is associated with elevated risk of erectile dysfunction: A systematic review and meta-analysis. Rheumatol Int 2019; 39(9): 1527-35.
[http://dx.doi.org/10.1007/s00296-019-04365-x] [PMID: 31278432]
[35]
Nakagawa T, Lanaspa MA, Johnson RJ. The effects of fruit consumption in patients with hyperuricaemia or gout. Rheumatol (United Kingdom) 2019; 58(7): 1133-41.
[36]
Towiwat P, Chhana A, Dalbeth N. The anatomical pathology of gout: A systematic literature review. BMC Musculoskelet Disord 2019; 20(1): 140.
[http://dx.doi.org/10.1186/s12891-019-2519-y] [PMID: 30935368]
[37]
Mitha A, Boulyana M, Hue V, Pruvost I, Martinot A, Dubos F. Consensus in diagnostic definitions for bone or joint infections in children by a Delphi method with European French-speaking experts. Acta Paediatr 2012; 101(8): e350-6.
[http://dx.doi.org/10.1111/j.1651-2227.2012.02716.x] [PMID: 22578155]
[38]
Sweet MC, Sheena GJ, Liu S, Fisk FE, Lynch JR, Muh SJ. Clinical characteristics and long-term outcomes after septic arthritis of the native glenohumeral joint: A 20-year retrospective review. Orthopedics 2019; 42(1): e118-23.
[http://dx.doi.org/10.3928/01477447-20181227-01] [PMID: 30602050]
[39]
Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF. Antibiotic penetration into bone and joints: An updated review. Int J Infect Dis 2019; 81: 128-36.
[http://dx.doi.org/10.1016/j.ijid.2019.02.005] [PMID: 30772469]
[40]
Mirza SZ, Richardson SS, Kahlenberg CA, et al. Diagnosing prosthetic joint infections in patients with inflammatory arthritis: A systematic literature review. J Arthroplasty 2019; 34(5): 1032-1036.e2.
[http://dx.doi.org/10.1016/j.arth.2019.01.051] [PMID: 30846314]
[41]
Meier R, Wirth T, Hahn F, Vögelin E, Sendi P. Pyogenic arthritis of the fingers and the wrist: Can we shorten antimicrobial treatment duration? Open Forum Infect Dis 2017; 4(2) ,ofx058.
[http://dx.doi.org/10.1093/ofid/ofx058] [PMID: 28491895]
[42]
Martinez-Rios C, Jariwala MP, Highmore K, et al. Imaging findings of sterile pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome: Differential diagnosis and review of the literature. Pediatr Radiol 2019; 49(1): 23-36.
[http://dx.doi.org/10.1007/s00247-018-4246-1] [PMID: 30225645]
[43]
Gardner RO, Kelley SP. Musculoskeletal infections. In: Alshryda S, Jones S, Banaszkiewicz PA, Eds.Postgraduate Paediatric Orthopaedics The Candidate’s Guide to the FRCS (Tr and Orth) Examination. Cambridge, UK: Cambridge University Press 2014; pp. 180-5.
[http://dx.doi.org/10.1017/CBO9781107415065.014]
[44]
Aupiais C, Ilharreborde B, Doit C, et al. Aetiology of arthritis in hospitalised children: An observational study. Arch Dis Child 2015; 100(8): 742-7.
[http://dx.doi.org/10.1136/archdischild-2014-307490] [PMID: 25732253]
[45]
García-Jiménez A, Prim N, Crusi X, Benito N. Septic arthritis due to Clostridium ramosum. Semin Arthritis Rheum 2016; 45(5): 617-20.
[http://dx.doi.org/10.1016/j.semarthrit.2015.09.009] [PMID: 26546506]
[46]
Shiel WC Jr. 2020.Available from:. https://www.medicinenet.com/septic_arthritis/article.htm
[47]
Long B, Koyfman A, Gottlieb M. Evaluation and management of septic arthritis and its mimics in the emergency department. West J Emerg Med 2019; 20(2): 331-41.
[http://dx.doi.org/10.5811/westjem.2018.10.40974] [PMID: 30881554]
[48]
Molloy R. Four ways to help prevent infection. US News and World Report in association with the medical experts at Cleveland Clinic. 2015. Available from: www.healthclevelandclinic.org/tag/infection
[49]
Vann MR. Preventing Infectious Arthritis 2011.Available from:. https://www.everydayhealth.com/rheumatic-diseases/preventing-infectious-arthritis.aspx
[50]
Spiegel L, Kristensen KD, Herlind T. Juvenile idiopathic arthritis characteristics: Etiology and pathophysiology. Semin Orthod 2015; 21(2): 77-83.
[http://dx.doi.org/10.1053/j.sodo.2015.02.003]
[51]
Farivar S, Hassani M, Shiari R. Interleukin-1 as a key factor in the development of inflammatory diseases. Arch Pediatr Infect Dis 2014; 2(4) ,e18177.
[http://dx.doi.org/10.5812/pedinfect.18177]
[52]
Armbrust W, Bos GJFJ, Geertzen JHB, Sauer PJJ, Dijkstra PU, Lelieveld OTHM. Measuring physical activity in juvenile idiopathic arthritis: Activity diary versus accelerometer. J Rheumatol 2017; 44(8): 1249-56.
[http://dx.doi.org/10.3899/jrheum.160671] [PMID: 28365580]
[53]
Ayaz NA. Karadağ SG, Çakmak F, Çakan M, Tanatar A, Sönmez HE. Leflunomide treatment in juvenile idiopathic arthritis. Rheumatol Int 2019; 39(9): 1615-9.
[http://dx.doi.org/10.1007/s00296-019-04385-7] [PMID: 31327053]
[54]
Mor-Vaknin N, Saha A, Legendre M, et al. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nat Commun 2017; 8: 14252.
[http://dx.doi.org/10.1038/ncomms14252] [PMID: 28165452]
[55]
Greene A. Juvenile idiopathic arthritis: A-to-Z Guide from diagnosis to treatment to prevention 2021.Available from:. https://www.drgreene.com/articles/juvenile-idiopathic-arthritis
[56]
Al-Afify ASA, El-Akabawy G, El-Sherif NM, El-Safty FEA, El-Habiby MM. Avocado soybean unsaponifiables ameliorates cartilage and subchondral bone degeneration in mono-iodoacetate-induced knee osteoarthritis in rats. Tissue Cell 2018; 52: 108-15.
[http://dx.doi.org/10.1016/j.tice.2018.05.001] [PMID: 29857819]
[57]
Buckwalter JA, Felson D. Post-traumatic arthritis: Definitions and burden of disease.In: Olson S, Guilak F, Eds Post-Traumatic Arthritis. Boston, MA, United States: Springer 2015; pp. 7-15.
[http://dx.doi.org/10.1007/978-1-4899-7606-2_2]
[58]
Pujalte GGA, Albano-Aluquin SA. Differential diagnosis of polyarticular arthritis. Am Fam Physician 2015; 92(1): 35-41.
[PMID: 26132125]
[59]
Bullough PG. The role of joint architecture in the etiology of arthritis. Osteoarthritis Cartilage 2004; 12(Suppl. A): S2-9.
[http://dx.doi.org/10.1016/j.joca.2003.09.010] [PMID: 14698635]
[60]
Hwang KA, Kwon JE, Noh Y, et al. Effects of Zanthoxylum piperitum ethanol extract on osteoarthritis inflammation and pain. Biomed Pharmacother 2018; 105: 481-90.
[http://dx.doi.org/10.1016/j.biopha.2018.05.109] [PMID: 29883943]
[61]
Galván-Tejada CE, López-Monteagudo FE, Alonso-González O, Moreno-Báez A, Celaya-Padilla JM, Zanella-Calzada LA. Image registration measures and chronic osteoarthritis knee pain prediction: Data from the Osteoarthritis Initiative. Rev Mex Ing Biomed 2019; 40(1): 1-13.
[62]
Stark K, Straub RH, Blazicková S, Hengstenberg C, Rovenský J. Genetics in neuroendocrine immunology: Implications for rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci 2010; 1193: 10-4.
[http://dx.doi.org/10.1111/j.1749-6632.2009.05288.x] [PMID: 20398001]
[63]
Rasheed N, Hafeez K, Zaidi IH, Askari R, Rasheed N, Khani GMK. Role of platelet-rich plasma in early osteoarthritis of knee joint: Experience from a tertiary care center in Pakistan. J Orthop Surg (Hong Kong) 2019; 27(2) ,2309499019853953.
[http://dx.doi.org/10.1177/2309499019853953] [PMID: 31177908]
[64]
Waters NP, Stoker AM, Carson WL, Pfeiffer FM, Cook JL. Biomarkers affected by impact velocity and maximum strain of cartilage during injury. J Biomech 2014; 47(12): 3185-95.
[http://dx.doi.org/10.1016/j.jbiomech.2014.06.015] [PMID: 25005436]
[65]
Lu H, Wang D, Li H, et al. GPR39 agonist TC-G 1008 ameliorates IL-1βinduced chondrocyte senescence. Artif Cells Nanomed Biotechnol 2019; 47(1): 2612-7.
[http://dx.doi.org/10.1080/21691401.2019.1626405] [PMID: 31237151]
[66]
Fathollahi A, Aslani S, Jamshidi A, Mahmoudi M. Epigenetics in osteoarthritis: Novel spotlight. J Cell Physiol 2019; 234(8): 12309-24.
[http://dx.doi.org/10.1002/jcp.28020] [PMID: 30659623]
[67]
Gong Z, Liu R, Yu W, Wong T, Guo Y. Preliminary therapeutic knee band development for knee osteoarthritis (koa) relief in the elderly: A pilot study. Adv Intell Syst Comput 2018; 795: 111-22.
[68]
Liu L, Yu Y, Fei Z, et al. An interpretable boosting model to predict side effects of analgesics for osteoarthritis. BMC Syst Biol 2018; 12(Suppl. 6): 105.
[http://dx.doi.org/10.1186/s12918-018-0624-4] [PMID: 30463545]
[69]
Lu M, Phillips D. Total hip arthroplasty for posttraumatic conditions. J Am Acad Orthop Surg 2019; 27(8): 275-85.
[http://dx.doi.org/10.5435/JAAOS-D-17-00775] [PMID: 30289797]
[70]
Zeng L, Rong XF, Li RH, Wu XY. Icariin inhibits MMP 1, MMP 3 and MMP 13 expression through MAPK pathways in IL 1β stimulated SW1353 chondrosarcoma cells. Mol Med Rep 2017; 15(5): 2853-8.
[http://dx.doi.org/10.3892/mmr.2017.6312] [PMID: 28447732]
[71]
Weiss AC, Goodman AD. Thumb basal joint arthritis. J Am Acad Orthop Surg 2018; 26(16): 562-71.
[http://dx.doi.org/10.5435/JAAOS-D-17-00374] [PMID: 29969109]
[72]
Fletcher J. Thumb arthritis: Symptoms, what to know. In: Medical News Today. In: 2018.
[73]
Dias R, Chandrasenan J, Rajaratnam V, Burke FD. Basal thumb arthritis. Postgrad Med J 2007; 83(975): 40-3.
[http://dx.doi.org/10.1136/pgmj.2006.046300] [PMID: 17267677]
[74]
Gottschalk MB, Patel NN, Boden AL, Kakar S. Treatment of basilar thumb arthritis: A critical analysis review. JBJS Rev 2018; 6(7) ,e4.
[http://dx.doi.org/10.2106/JBJS.RVW.17.00156] [PMID: 29994801]
[75]
Wagner WF. Why ligament reconstruction, tendon interposition arthroplasty fails, and salvaging failed ligament reconstruction, tendon interposition arthroplasty. Curr Opin Orthop 2006; 17(4): 288-94.
[http://dx.doi.org/10.1097/01.bco.0000233719.10892.bd]
[76]
Bagel J, Schwartzman S. Enthesitis and dactylitis in psoriatic disease: A guide for dermatologists. Am J Clin Dermatol 2018; 19(6): 839-52.
[http://dx.doi.org/10.1007/s40257-018-0377-2] [PMID: 30117018]
[77]
Bardazzi F, Starace M, Bruni F, Magnano M, Piraccini BM, Alessandrini A. Nail psoriasis: An updated review and expert opinion on available treatments, including biologics. Acta Derm Venereol 2019; 99(6): 516-23.
[http://dx.doi.org/10.2340/00015555-3098] [PMID: 30521057]
[78]
Gisondi P, Del Giglio M, Girolomoni G. Considerations for systemic treatment of psoriasis in obese patients. Am J Clin Dermatol 2016; 17(6): 609-15.
[http://dx.doi.org/10.1007/s40257-016-0211-7] [PMID: 27411805]
[79]
Chimenti MS, Caso F, Alivernini S, et al. Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease. Autoimmun Rev 2019; 18(6): 565-75.
[http://dx.doi.org/10.1016/j.autrev.2018.11.007] [PMID: 30959209]
[80]
Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34(3): J314-21.
[http://dx.doi.org/10.1016/j.jaut.2009.12.001] [PMID: 20034760]
[81]
Migkos MP, Somarakis GP, Markatseli TE, Voulgari PV, Drosos AA. Epidemiological characteristics of psoriatic arthritis. Clin Exp Rheumatol 2019; 37(2): 324-32.
[PMID: 30299245]
[82]
Visalli E, Crispino N, Foti R. Multidisciplinary management of psoriatic arthritis: The benefits of a comprehensive approach. Adv Ther 2019; 36(4): 806-16.
[http://dx.doi.org/10.1007/s12325-019-00901-0] [PMID: 30805821]
[83]
Bedaiwi M, Al-Homood IA, El-Garf A, et al. Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East. Rheumatol Int 2019; 39(8): 1321-9.
[http://dx.doi.org/10.1007/s00296-019-04319-3] [PMID: 31134289]
[84]
Bergman M, Lundholm A. Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis. Arthritis Res Ther 2017; 19(1): 63.
[http://dx.doi.org/10.1186/s13075-017-1265-5] [PMID: 28320454]
[85]
Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol 2019; 5(3): 141-50.
[http://dx.doi.org/10.1016/j.ijwd.2019.04.021] [PMID: 31360745]
[86]
Madonna S, Girolomoni G, Dinarello CA, Albanesi C. The significance of IL-36 hyperactivation and il-36r targeting in psoriasis. Int J Mol Sci 2019; 20(13): 3318.
[http://dx.doi.org/10.3390/ijms20133318] [PMID: 31284527]
[87]
Razawy W, van Driel M, Lubberts E. The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling. Eur J Immunol 2018; 48(2): 220-9.
[http://dx.doi.org/10.1002/eji.201646787] [PMID: 29148561]
[88]
McGonagle DG, McInnes IB, Kirkham BW, Sherlock J, Moots R. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: Recent advances and controversies. Ann Rheum Dis 2019; 78(9): 1167-78.
[http://dx.doi.org/10.1136/annrheumdis-2019-215356] [PMID: 31278139]
[89]
Ferguson LD, Siebert S, McInnes IB, Sattar N. Cardiometabolic comorbidities in RA and PsA: Lessons learned and future directions. Nat Rev Rheumatol 2019; 15(8): 461-74.
[http://dx.doi.org/10.1038/s41584-019-0256-0] [PMID: 31292564]
[90]
Natarajan R. Secukinumab: A safe option to treat psoriasis and psoriatic arthritis in the presence of interstitial lung disease. Indian J Rheumatol 2019; 14(2): 145-50.
[http://dx.doi.org/10.4103/injr.injr_4_19]
[91]
Villines Z. Can you prevent psoriatic arthritis? 2019.Available from:. https://www.medicalnewstoday.com/articles/326883
[92]
Arthritis Mayo Clinic. 2019. Available from:. https://www.google.com/search?client=firefox-bd&q=Mayo+Clinic+Staff.+2019.+Arthritis+Mayo+Clinic.+Reactive+arthritis+Symptoms+%26+causes+Diagnosis+%26+treatment.+Last+updated+on+Oct+02%2C+2019.++++
[93]
Tekgöz E, Cinar M, Yilmaz S, Rebanta K, Chakraborty RK, Ramphul K. A rare cause of reactive arthritis etiology: Bacillus calmette-guerin immunotherapy. Gülhane Tip Derg 2019; 61(1): 28-9.
[http://dx.doi.org/10.26657/gulhane.00049]
[94]
Coba GA, Velez AP, Joyce DM, Greene JN. Contrasting the clinical presentation and prevalence of septic, reactive, and crystal arthritis in patients with hematologic and solid malignancies. Infect Dis Clin Pract 2019; 27(2): 96-101.
[http://dx.doi.org/10.1097/IPC.0000000000000712]
[95]
Brooks PM. Rheumatoid arthritis: Aetiology and clinical features. Medicine (United States) 2006; 34(10): 379-82.
[96]
Amital A, Shitrit D, Adir Y. The lung in rheumatoid arthritis. Presse Med 2011; 40(1 Pt 2): e31-48.
[PMID: 21196098]
[97]
Rashid T, Ebringer A, Wilson C. The link between proteus mirabilis, environmental factors and autoantibodies in rheumatoid arthritis. Clin Exp Rheumatol 2017; 35(5): 865-71.
[PMID: 28516867]
[98]
DeChristopher LR, Uribarri J, Tucker KL. Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20-30 years. Nutr Diabetes 2016; 6(3) ,e199.
[http://dx.doi.org/10.1038/nutd.2016.7] [PMID: 26950480]
[99]
Glant TT, Mikecz K, Rauch TA. Epigenetics in the pathogenesis of rheumatoid arthritis. BMC Med 2014; 12: 35.
[http://dx.doi.org/10.1186/1741-7015-12-35]
[100]
Esposito AJ, Chu SG, Madan R, Doyle TJ, Dellaripa PF. Thoracic manifestations of rheumatoid arthritis. Clin Chest Med 2019; 40(3): 545-60.
[http://dx.doi.org/10.1016/j.ccm.2019.05.003] [PMID: 31376890]
[101]
Agonia I, Couras J, Cunha A, Andrade AJ, Macedo J, Sousa-Pinto B. IL-17, IL-21 and IL-22 polymorphisms in rheumatoid arthritis: A systematic review and meta-analysis. Cytokine 2020; 125 ,154813.
[http://dx.doi.org/10.1016/j.cyto.2019.154813] [PMID: 31454755]
[102]
Fu J, Nogueira SV, Drongelen VV, et al. Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of gene-environment interaction in autoimmune arthritis. Proc Natl Acad Sci USA 2018; 115(18): 4755-60.
[http://dx.doi.org/10.1073/pnas.1722124115] [PMID: 29666259]
[103]
Kabul EG, Aslan UB. Başakçı Çalık B, Taşçı M, Çobankara V Exploring the relation between impairment rating by DAS-28 and body function, activity participation, and environmental factors based on ICF hand core set in the patient with rheumatoid arthritis. Rheumatol Int 2018; 38(7): 1267-75.
[http://dx.doi.org/10.1007/s00296-018-4060-y] [PMID: 29850963]
[104]
Bacon M C, White P H, Raiten D J. Nutritional status and growth in juvenile rheumatoid arthritis. Semin Arthritis Rheumatol 20(2): 97-106.
[http://dx.doi.org/10.1016/0049-0172(90)90022-8]
[105]
Giles JT. Extra-articular manifestations and comorbidity in rheumatoid arthritis: Potential impact of pre-rheumatoid arthritis prevention. Clin Ther 2019; 41(7): 1246-55.
[http://dx.doi.org/10.1016/j.clinthera.2019.04.018] [PMID: 31196641]
[106]
Worthington J. Gene behind Rheumatoid Arthritis identifiedSci News 2007 Available from: https://www.sciencedaily.com/releases/2007/11/071104190626.htm
[107]
Shinde SS, Deshmukh AS, Nagadkar PP. Management of rheumatoid arthritis and monitoring of drug therapy: A review. Int J Pharm Sci Rev Res 2014; 29(1): 42-5.
[108]
Chehade L, Jaafar ZA, El Masri D, et al. Lifestyle modification in rheumatoid arthritis: Dietary and physical activity recommendations based on evidence. Curr Rheumatol Rev 2019; 15(3): 209-14.
[http://dx.doi.org/10.2174/1573397115666190121135940] [PMID: 30666911]
[109]
Salmon VE, Hewlett S, Walsh NE, et al. Developing a group intervention to manage fatigue in rheumatoid arthritis through modifying physical activity. BMC Musculoskelet Disord 2019; 20(1): 194.
[http://dx.doi.org/10.1186/s12891-019-2558-4] [PMID: 31054567]
[110]
Nessen T, Opava CH, Demmelmaier I. Physiotherapists’ adoption of a theory-based skills training program in guiding people with rheumatoid arthritis to health-enhancing physical activity. Int J Behav Med 2018; 25(4): 438-47.
[http://dx.doi.org/10.1007/s12529-018-9716-1] [PMID: 29971578]
[111]
Srikesavan C, Bryer C, Ali U, Williamson E. Web-based rehabilitation interventions for people with rheumatoid arthritis: A systematic review. J Telemed Telecare 2019; 25(5): 263-75.
[http://dx.doi.org/10.1177/1357633X18768400] [PMID: 29669470]
[112]
Fenton SAM, Veldhuijzen van Zanten JJCS, Kitas GD, et al. Sedentary behaviour is associated with increased long-term cardiovascular risk in patients with rheumatoid arthritis independently of moderate-to-vigorous physical activity. BMC Musculoskelet Disord 2017; 18(1): 131.
[http://dx.doi.org/10.1186/s12891-017-1473-9] [PMID: 28356089]
[113]
Stamp LK, James MJ, Cleland LG. Diet and rheumatoid arthritis: A review of the literature. Semin Arthritis Rheum 2005; 35(2): 77-94.
[http://dx.doi.org/10.1016/j.semarthrit.2005.05.001] [PMID: 16194694]
[114]
Abdullah AZ, Bukhari A, Aliyah BA, Usman AN. Potential honey propolis trigona to prevent arthritis rheumatoid by increase Foxp3 Level; A preliminary study. Indian J Public Health Res Dev 2018; 9(12): 1353-8.
[http://dx.doi.org/10.5958/0976-5506.2018.02041.7]
[115]
Capellino S. Dopaminergic agents in rheumatoid arthritis. J Neuroimmune Pharmacol 2020; 15(1): 48-56.
[http://dx.doi.org/10.1007/s11481-019-09850-5] [PMID: 31016462]
[116]
Forsyth C, Kouvari M, D’Cunha NM, et al. The effects of the mediterranean diet on rheumatoid arthritis prevention and treatment: A systematic review of human prospective studies. Rheumatol Int 2018; 38(5): 737-47.
[http://dx.doi.org/10.1007/s00296-017-3912-1] [PMID: 29256100]
[117]
Asteriou E, Gkoutzourelas A, Mavropoulos A, Katsiari C, Sakkas LI, Bogdanos DP. Curcumin for the management of periodontitis and early ACPA-positive rheumatoid arthritis: Killing two birds with one stone. Nutrients 2018; 10(7): 908.
[http://dx.doi.org/10.3390/nu10070908] [PMID: 30012973]
[118]
Zaccardelli A, Friedlander HM, Ford JA, Sparks JA. Potential of lifestyle changes for reducing the risk of developing rheumatoid arthritis: Is an ounce of prevention worth a pound of cure? Clin Ther 2019; 41(7): 1323-45.
[http://dx.doi.org/10.1016/j.clinthera.2019.04.021] [PMID: 31196646]
[119]
Zavvar M, Assadiasl S, Soleimanifar N, et al. Gene therapy in rheumatoid arthritis: Strategies to select therapeutic genes. J Cell Physiol 2019; 234(10): 16913-24.
[http://dx.doi.org/10.1002/jcp.28392] [PMID: 30809802]
[120]
Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol 2017; 31(1): 3-18.
[http://dx.doi.org/10.1016/j.berh.2017.08.003] [PMID: 29221595]
[121]
McKenna S, Kelly G, Kennedy N. A survey of physiotherapists’ current management and the promotion of physical activity, in people with rheumatoid arthritis. Disabil Rehabil 2019; 41(18): 2183-91.
[http://dx.doi.org/10.1080/09638288.2018.1461258] [PMID: 29644891]
[122]
Shiu WH, Wong TK, Chao DVK. A review on the diagnosis and management of rheumatoid arthritis in general practice. Hong Kong Pract 2018; 40(2): 61-72.

Rights & Permissions Print Cite
Article Metrics
13
1
© 2024 Bentham Science Publishers | Privacy Policy